Associated Papers
Traditional and New Views on MSI-H/dMMR Endometrial Cancer.
Liu C et al.
Biomolecules, 2025
Synchronous endometrial and ovarian cancer in Lynch syndrome with a MSH2 germline mutation: A case report.
Takeda T et al.
Molecular and Clinical Oncology, 2018
Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
Pritchard AL et al.
Plos One, 2018
29641532 (PubMed )
Supplement: pone.0194098.s003.xlsx › UK10K_DNArep
Targeted sequencing of established and candidate colorectal cancer genes in the Colon Cancer Family Registry Cohort.
Raskin L et al.
Oncotarget, 2017
29212164 (PubMed )
Supplement: oncotarget-08-93450-s002.xlsx › Sup.Table1-All_rare_variants
Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes.
DeRycke MS et al.
Molecular Genetics & Genomic Medicine, 2017
28944238 (PubMed )
Supplement: MGG3-5-553-s002.xlsx › ST2
Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome.
Ou J et al.
Genes, Chromosomes & Cancer, 2009
The first functional study of MLH3 mutations found in cancer patients.
Korhonen MK et al.
Genes, Chromosomes & Cancer, 2008
No association between two MLH3 variants (S845G and P844L)and colorectal cancer risk.
de Jong MM et al.
Cancer Genetics and Cytogenetics, 2004
A role for MLH3 in hereditary nonpolyposis colorectal cancer.
Wu Y et al.
Nature Genetics, 2001
Select a paper to view details